AI and Autonomy AI-designed drugs near human trials as AlphaFold enters clinical phase Isomorphic Labs launched in 2021 as a unit of Alphabet Inc Joseph Morton3 days ago
Medical and Pharmaceutical New blood test approach could detect multiple cancers earlier, researchers say Scientists have long sought easier ways to identify cancer sooner Joseph Morton5 days ago
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical Oregon State nanomaterial eradicates breast cancer tumours in mice In mouse experiments using human breast cancer tumors, the results were striking Joseph MortonFebruary 10, 2026
Medical and Pharmaceutical Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients Lung cancer kills more people than colon, breast and prostate cancers combined Joseph MortonDecember 16, 2025
AI and Autonomy Artificial intelligence boosts accuracy of pancreatic cancer diagnosis Pancreatic ductal adenocarcinoma remains one of the deadliest cancers in the world Joseph MortonDecember 1, 2025
Medical and Pharmaceutical Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects Abbott earned billions during the Covid-19 pandemic by selling millions of Covid tests and testing kits Joseph MortonNovember 20, 2025
Medical and Pharmaceutical Famous skateboarder Tony Hawk advocates for lung cancer screening Hawk is a spokesman for Cancerguard: a multi-cancer detection test Rowan DunneNovember 19, 2025
Medical and Pharmaceutical Galleri shows promise in large U.S. based clinical trial Researchers believe this approach could allow doctors to catch cancers much earlier Joseph MortonOctober 20, 2025